189 related articles for article (PubMed ID: 25226384)
1. Hibiscus sabdariffa polyphenols alleviate insulin resistance and renal epithelial to mesenchymal transition: a novel action mechanism mediated by type 4 dipeptidyl peptidase.
Peng CH; Yang YS; Chan KC; Wang CJ; Chen ML; Huang CN
J Agric Food Chem; 2014 Oct; 62(40):9736-43. PubMed ID: 25226384
[TBL] [Abstract][Full Text] [Related]
2. Hibiscus sabdariffa polyphenols prevent palmitate-induced renal epithelial mesenchymal transition by alleviating dipeptidyl peptidase-4-mediated insulin resistance.
Huang CN; Wang CJ; Yang YS; Lin CL; Peng CH
Food Funct; 2016 Jan; 7(1):475-82. PubMed ID: 26514092
[TBL] [Abstract][Full Text] [Related]
3. Polyphenols of Hibiscus sabdariffa improved diabetic nephropathy via attenuating renal epithelial mesenchymal transition.
Yang YS; Wang CJ; Huang CN; Chen ML; Chen MJ; Peng CH
J Agric Food Chem; 2013 Aug; 61(31):7545-51. PubMed ID: 23848500
[TBL] [Abstract][Full Text] [Related]
4. The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice.
Schürmann C; Linke A; Engelmann-Pilger K; Steinmetz C; Mark M; Pfeilschifter J; Klein T; Frank S
J Pharmacol Exp Ther; 2012 Jul; 342(1):71-80. PubMed ID: 22493041
[TBL] [Abstract][Full Text] [Related]
5. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
Kanasaki K; Shi S; Kanasaki M; He J; Nagai T; Nakamura Y; Ishigaki Y; Kitada M; Srivastava SP; Koya D
Diabetes; 2014 Jun; 63(6):2120-31. PubMed ID: 24574044
[TBL] [Abstract][Full Text] [Related]
6. Polyphenol extracts from Hibiscus sabdariffa Linnaeus attenuate nephropathy in experimental type 1 diabetes.
Lee WC; Wang CJ; Chen YH; Hsu JD; Cheng SY; Chen HC; Lee HJ
J Agric Food Chem; 2009 Mar; 57(6):2206-10. PubMed ID: 19219995
[TBL] [Abstract][Full Text] [Related]
7. Hibiscus sabdariffa polyphenolic extract inhibits hyperglycemia, hyperlipidemia, and glycation-oxidative stress while improving insulin resistance.
Peng CH; Chyau CC; Chan KC; Chan TH; Wang CJ; Huang CN
J Agric Food Chem; 2011 Sep; 59(18):9901-9. PubMed ID: 21870884
[TBL] [Abstract][Full Text] [Related]
8. The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
Tsuprykov O; Ando R; Reichetzeder C; von Websky K; Antonenko V; Sharkovska Y; Chaykovska L; Rahnenführer J; Hasan AA; Tammen H; Alter M; Klein T; Ueda S; Yamagishi SI; Okuda S; Hocher B
Kidney Int; 2016 May; 89(5):1049-1061. PubMed ID: 27083282
[TBL] [Abstract][Full Text] [Related]
9. Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
Shi S; Srivastava SP; Kanasaki M; He J; Kitada M; Nagai T; Nitta K; Takagi S; Kanasaki K; Koya D
Kidney Int; 2015 Sep; 88(3):479-89. PubMed ID: 25830763
[TBL] [Abstract][Full Text] [Related]
10. Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice.
Darsalia V; Olverling A; Larsson M; Mansouri S; Nathanson D; Nyström T; Klein T; Sjöholm Å; Patrone C
Regul Pept; 2014 May; 190-191():25-31. PubMed ID: 24821550
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
12. Hibiscus sabdariffa (roselle) polyphenol-rich extract averts cardiac functional and structural abnormalities in type 1 diabetic rats.
Mohammed Yusof NL; Zainalabidin S; Mohd Fauzi N; Budin SB
Appl Physiol Nutr Metab; 2018 Dec; 43(12):1224-1232. PubMed ID: 29726706
[TBL] [Abstract][Full Text] [Related]
13. Linagliptin blocks renal damage in type 1 diabetic rats by suppressing advanced glycation end products-receptor axis.
Nakashima S; Matsui T; Takeuchi M; Yamagishi SI
Horm Metab Res; 2014 Sep; 46(10):717-21. PubMed ID: 24710699
[TBL] [Abstract][Full Text] [Related]
14. The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin.
Kanasaki K
Clin Sci (Lond); 2018 Feb; 132(4):489-507. PubMed ID: 29491123
[TBL] [Abstract][Full Text] [Related]
15. Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats.
Peng CH; Lin HC; Lin CL; Wang CJ; Huang CN
J Food Drug Anal; 2019 Jan; 27(1):135-144. PubMed ID: 30648566
[TBL] [Abstract][Full Text] [Related]
16. Linagliptin but not Sitagliptin inhibited transforming growth factor-β2-induced endothelial DPP-4 activity and the endothelial-mesenchymal transition.
Shi S; Kanasaki K; Koya D
Biochem Biophys Res Commun; 2016 Feb; 471(1):184-90. PubMed ID: 26826382
[TBL] [Abstract][Full Text] [Related]
17. Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype rats.
Retlich S; Withopf B; Greischel A; Staab A; Jaehde U; Fuchs H
Biopharm Drug Dispos; 2009 Nov; 30(8):422-36. PubMed ID: 19771584
[TBL] [Abstract][Full Text] [Related]
18. (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors.
Thomas L; Eckhardt M; Langkopf E; Tadayyon M; Himmelsbach F; Mark M
J Pharmacol Exp Ther; 2008 Apr; 325(1):175-82. PubMed ID: 18223196
[TBL] [Abstract][Full Text] [Related]
19. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S
Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice.
Takagaki Y; Shi S; Katoh M; Kitada M; Kanasaki K; Koya D
Sci Rep; 2019 May; 9(1):7519. PubMed ID: 31101909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
